A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer
Title:
A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer
Author:
Jacobs, C. Kuchuk, I. Bouganim, N. Smith, S. Mazzarello, S. Vandermeer, L. Dranitsaris, G. Dent, S. Gertler, S. Verma, S. Song, X. Simos, S. Cella, D. Clemons, M.